In an interview with Targeted Oncology™, Q2 2023 Oncology Icons honoree, Thaddeus Beck, MD, FACP, discussed his 30 plus years of experience in clinical practice.
ONCare Alliance
Latest Content
In an interview with Targeted Oncology, Q2 2023 Oncology Icons honoree, Tara Graff, DO, MS, discusses her path to community oncology from academia, and hopes to continue to advance community-based research in the future.
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Advanced Renal Cell Carcinoma: Selecting Between IO/TKI and IO/IO Combination Therapy
2
FDA Approves Perioperative Pembrolizumab Plus Enfortumab Vedotin for MIBC
3
FDA Approves Subcutaneous Isatuximab for Multiple Myeloma
4
First Patient Treated With PSMA-Targeted Actinium-225 Alpha Emitter in mCRPC
5